VVT Medical
TSXv:VVTMYokneam, Israel· Est.
Israeli med‑tech firm delivering non‑thermal, catheter‑based vein‑closure solutions for varicose veins and related venous disorders.
Is this your company? Claim your profile to update info and connect with investors.
Claim profileAI Company Overview
Israeli med‑tech firm delivering non‑thermal, catheter‑based vein‑closure solutions for varicose veins and related venous disorders.
Venous diseaseVaricose veins
Technology Platform
Proprietary mechanochemical technology that combines controlled sclerosant injection, simultaneous vessel collapse, and blood aspiration to achieve non‑thermal vein closure.
Opportunities
Expansion into U.S., European and Asian markets leveraging FDA clearance and non‑thermal advantage; potential addition of new venous indications and procedural combos.
Risk Factors
Clinical adoption may be slower than anticipated; competition from established thermal and other non‑thermal ablation devices; regulatory approvals in additional regions could delay growth.
Competitive Landscape
Competes with thermal ablation (laser, RF) and non‑thermal devices such as VenaSeal and ClariVein; differentiation lies in its dual‑mode mechanochemical approach that aims to reduce pain and side effects while covering a broader vein size range.